|
JP4564713B2
(ja)
|
2000-11-01 |
2010-10-20 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
|
|
CA2494710C
(en)
|
2002-10-15 |
2011-05-03 |
Otsuka Pharmaceutical Co., Ltd. |
1-substituted-4-nitroimidazole compound and method for preparing the same
|
|
PT1678185E
(pt)
|
2003-10-31 |
2009-01-13 |
Otsuka Pharma Co Ltd |
Compostos 2,3-di-hidro-6-nitroimidazo[2,1-b]oxazole para o tratamento da tuberculose
|
|
JP4761756B2
(ja)
*
|
2003-10-31 |
2011-08-31 |
大塚製薬株式会社 |
２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
|
|
TWI300409B
(en)
|
2004-02-18 |
2008-09-01 |
Otsuka Pharma Co Ltd |
Method for producing 4-nitroimidazole compound
|
|
AU2005228289B2
(en)
|
2004-03-31 |
2008-01-10 |
Nippon Soda Co., Ltd. |
Cyclic amine compound and pest control agent
|
|
JP4789966B2
(ja)
*
|
2004-04-09 |
2011-10-12 |
大塚製薬株式会社 |
医薬組成物
|
|
JP4787529B2
(ja)
*
|
2004-04-09 |
2011-10-05 |
大塚製薬株式会社 |
医薬組成物
|
|
ATE450525T1
(de)
*
|
2005-06-20 |
2009-12-15 |
Schering Corp |
Kohlenstoffgebundene substituierte piperidine und derivate daraus als histamin-h3-antagonisten
|
|
PT1906926E
(pt)
*
|
2005-07-28 |
2011-01-26 |
Otsuka Pharma Co Ltd |
Composição farmacêutica que contém derivados de 2,3-di-hidro-6-nitroimidazo[2,1-b]oxazole
|
|
TWI368509B
(en)
*
|
2005-10-05 |
2012-07-21 |
Otsuka Pharma Co Ltd |
Antituberculous therapeutic drugs and kit containing the same
|
|
JP5105818B2
(ja)
*
|
2005-10-05 |
2012-12-26 |
大塚製薬株式会社 |
医薬組成物
|
|
MY141762A
(en)
|
2005-10-06 |
2010-06-30 |
Nippon Soda Co |
Cross-linked cyclic amine compounds and agents for pest control
|
|
TW200800268A
(en)
*
|
2005-11-04 |
2008-01-01 |
Otsuka Pharma Co Ltd |
Medicinal composition showing improved drug absorbability
|
|
CA2636929A1
(en)
*
|
2005-12-21 |
2007-07-12 |
Decode Genetics, Ehf |
Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
|
|
WO2007093557A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Laboratoires Serono S.A. |
Sulfonamide derivatives for the treatment of bacterial infections
|
|
JP2007297305A
(ja)
*
|
2006-04-28 |
2007-11-15 |
Daiso Co Ltd |
Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
|
|
CA2678577A1
(en)
*
|
2007-02-26 |
2008-09-04 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
AR070301A1
(es)
|
2007-05-08 |
2010-03-31 |
Otsuka Pharma Co Ltd |
Compuesto epoxi y metodo para producir el mismo
|
|
JP5470557B2
(ja)
*
|
2007-07-26 |
2014-04-16 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
|
|
PE20090595A1
(es)
*
|
2007-08-15 |
2009-06-06 |
Glaxo Group Ltd |
Derivados de quinoliniloxipiperidina y pirrolidina como antagonistas del receptor h1
|
|
EP2205585A1
(en)
*
|
2007-10-16 |
2010-07-14 |
Glaxo Group Limited |
Quinoline derivatives used to treat inflammatory and allergic diseases
|
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
US8440658B2
(en)
|
2007-12-11 |
2013-05-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
WO2009094169A1
(en)
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CA2714532A1
(en)
*
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
US8598160B2
(en)
*
|
2008-02-15 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
WO2009117109A1
(en)
*
|
2008-03-18 |
2009-09-24 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
JP5613656B2
(ja)
*
|
2008-03-26 |
2014-10-29 |
グローバル、アライアンス、フォア、ティービー、ドラッグ、ディベロップメント |
置換されたフェニルオキサゾリジノンと共有結合した二環式ニトロイミダゾール
|
|
RU2531272C2
(ru)
|
2008-05-01 |
2014-10-20 |
Вайтаи Фармасьютиклз, Инк. |
Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
|
|
US8242111B2
(en)
*
|
2008-05-01 |
2012-08-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
JP5696037B2
(ja)
|
2008-05-01 |
2015-04-08 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
EP2291370B1
(en)
|
2008-05-01 |
2013-11-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2010010157A2
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
|
|
NZ590495A
(en)
|
2008-07-25 |
2012-10-26 |
Vitae Pharmaceuticals Inc |
Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US20120040974A1
(en)
*
|
2008-08-18 |
2012-02-16 |
Yale University |
Mif modulators
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
WO2010143007A1
(en)
*
|
2009-06-10 |
2010-12-16 |
Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik |
Method for the production of 2-halogeno-4-nitroimidazole
|
|
EP2323990B1
(en)
*
|
2008-08-21 |
2014-06-18 |
Dynamit Nobel GmbH Explosivstoff- und Systemtechnik |
Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
|
|
JP5679997B2
(ja)
|
2009-02-04 |
2015-03-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
|
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
|
GEP20156309B
(en)
*
|
2009-04-30 |
2015-07-10 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8680093B2
(en)
|
2009-04-30 |
2014-03-25 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8927539B2
(en)
|
2009-06-11 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
|
|
EP2448928B1
(en)
|
2009-07-01 |
2014-08-13 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
BR112012002214B1
(pt)
|
2009-07-31 |
2022-01-25 |
Global Alliance For Tb Drug Development |
Análogos de nitroimidazooxazina e nitroimidazooxazol, seus usos e composição farmacêutica
|
|
US9198913B2
(en)
|
2009-07-31 |
2015-12-01 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazines and their uses in anti-tubercular therapy
|
|
CA2769359C
(en)
*
|
2009-07-31 |
2017-03-07 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazines and their uses in anti-tubercular therapy
|
|
JP5770096B2
(ja)
|
2009-10-26 |
2015-08-26 |
富士フイルムＲｉファーマ株式会社 |
感染症診断薬
|
|
TW201200523A
(en)
|
2010-01-29 |
2012-01-01 |
Otsuka Pharma Co Ltd |
Synthetic intermediate of oxazole compound and method for producing the same
|
|
GB201012209D0
(en)
*
|
2010-05-31 |
2010-09-08 |
Ge Healthcare Ltd |
In vivo imaging agent
|
|
WO2011159760A1
(en)
|
2010-06-16 |
2011-12-22 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
|
WO2011161128A1
(en)
|
2010-06-25 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
|
WO2012059416A1
(en)
|
2010-11-02 |
2012-05-10 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations for the treatment of metabolic disorders
|
|
US9051333B2
(en)
|
2011-04-15 |
2015-06-09 |
Otsuka Pharmaceutical Co., Ltd. |
6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
|
|
JP2015006994A
(ja)
*
|
2011-10-28 |
2015-01-15 |
大正製薬株式会社 |
ジヒドロイミダゾオキサゾール誘導体
|
|
WO2014014845A1
(en)
|
2012-07-18 |
2014-01-23 |
Vertex Pharmaceuticals Incorporated |
Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
|
|
FR3000064A1
(fr)
|
2012-12-21 |
2014-06-27 |
Univ Lille Ii Droit & Sante |
Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
|
|
IN2013DE02954A
(https=)
|
2013-10-04 |
2015-04-10 |
Council Scient Ind Res |
|
|
CN103524492A
(zh)
*
|
2013-10-23 |
2014-01-22 |
中国药科大学 |
侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
|
|
TWI687409B
(zh)
|
2014-08-28 |
2020-03-11 |
日商大塚製藥股份有限公司 |
稠合雜環化合物
|
|
EP3209669B1
(en)
*
|
2014-10-21 |
2018-11-07 |
Council of Scientific and Industrial Research |
Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
|
|
CN105732659B
(zh)
*
|
2014-12-12 |
2019-07-16 |
上海阳帆医药科技有限公司 |
硝基咪唑类化合物及其制备方法和在制药中的用途
|
|
WO2016119706A1
(zh)
*
|
2015-01-29 |
2016-08-04 |
南京明德新药研发股份有限公司 |
抗肺结核病的硝基咪唑衍生物
|
|
EA201792154A1
(ru)
*
|
2015-03-27 |
2018-02-28 |
Оцука Фармасьютикал Ко., Лтд. |
Способ получения 1-(4-гидроксифенил)-4-(4- трифторметоксифенокси)пиперидина или его соли
|
|
CN106317072B
(zh)
*
|
2015-06-17 |
2020-03-17 |
盟科医药技术(上海)有限公司 |
用于分枝杆菌感染治疗的杂环化合物及其应用
|
|
CN105859628B
(zh)
*
|
2016-04-19 |
2018-08-07 |
清远职业技术学院 |
一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
|
|
US20190276475A1
(en)
*
|
2016-07-22 |
2019-09-12 |
Medshine Discovery Inc. |
Crystal and salt of nitroimidazole, and manufacturing method thereof
|
|
PT3668879T
(pt)
*
|
2017-08-16 |
2021-12-02 |
BioVersys AG |
Novos compostos
|
|
US20210251902A1
(en)
|
2018-06-11 |
2021-08-19 |
Otsuka Pharmaceutical Co., Ltd. |
Delamanid-containing composition
|
|
CN109705022A
(zh)
*
|
2018-12-28 |
2019-05-03 |
上海彩迩文生化科技有限公司 |
一种芳香胺中间体的制备方法
|
|
CN112300192B
(zh)
*
|
2019-08-02 |
2023-08-11 |
南京长澳医药科技有限公司 |
硝基咪唑类化合物及其制备方法和用途
|
|
CN110483549B
(zh)
*
|
2019-08-30 |
2021-03-05 |
沈阳药科大学 |
一种硝基咪唑吡喃类抗结核药物的制备方法
|
|
CN110615800A
(zh)
*
|
2019-10-16 |
2019-12-27 |
李丽丽 |
硝基咪唑类化合物及其制备方法和用途
|
|
CN112156088B
(zh)
*
|
2020-10-30 |
2021-08-31 |
健民药业集团股份有限公司 |
一种化合物在制备结核分枝杆菌抑制剂中的用途
|
|
CN113603706A
(zh)
*
|
2021-08-04 |
2021-11-05 |
深圳市泰力生物医药有限公司 |
德拉马尼的晶型、含有该晶型的活性药物和药物组合物
|
|
EP4563147A1
(en)
|
2022-07-29 |
2025-06-04 |
Otsuka Pharmaceutical Co., Ltd. |
Delamanid-containing solid dispersion
|
|
CN115368252B
(zh)
*
|
2022-09-19 |
2024-01-12 |
西北农林科技大学 |
一种4-胺基酚类衍生物及应用
|
|
CN116640106B
(zh)
*
|
2023-05-11 |
2024-03-08 |
郑州大学 |
一种苯基哌嗪类化合物及其制备方法、应用
|
|
CN119059990B
(zh)
*
|
2024-11-01 |
2025-02-07 |
安徽昊帆生物有限公司 |
1-氨基甲酸叔丁酯哌嗪的制备方法
|